Federal prosecutors said the defendants encouraged low-income patients to sell their medication to them and then resold the drugs and used the money to buy luxury goods.
https://siii-clinical.com/wp-content/uploads/2021/09/Untitled-1.png00https://siii-clinical.com/wp-content/uploads/2021/09/Untitled-1.png2023-10-21 03:33:462023-10-21 03:33:4610 Charged in $20 Million Scheme to Sell Black-Market H.I.V. Drugs
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.